CA 66: 37835q (1967). |
CA 99: 158321j (1983). |
Bodor et al., Science 190, 155-156 (1975). |
Shek et al., J. Med. Chem. 19, 113-117 (1976). |
Bodor et al., in Design of Biopharmaceutical Properties through Prodrugs and Analogs, ed. Edward B. Roche, American Pharmaceutical Association, Washington, D.C., 98-135 (1977). |
Bodor et al., J. Pharm. Sci. 67, 685-687 (1978). |
Bodor et al., Science 214, 1370-1372 (1981). |
The Friday Evening Post, Health Center Communications, University of Florida, Gainesville, Fla., Aug. 14, 1981. |
Chemical and Engineering News, pp. 24-25, Dec. 21, 1981. |
Science News, vol. 121, #1, p. 7, Jan. 2, 1982. |
Brewster, III, Dis. Abst. Int. B., vol. 43, #9, p. 2910B (1983). |
Bodor et al., J. Medl Chem. 26, 313-318, 528-534 (1983). |
Bodor et al., Pharmac. Ther. 19, 337-386 (1983). |
Bodor et al., J. Pharm. Sci. 73, 385-389 (1984). |
Bodor et al., Science 221, 65-67 (1983). |
Pop, E. et al., CA 111(17): 153459g (1989). |
J. Med. Chem. 32(8), 1789-95. |
Wu, W. et al., CA 111(8): 63813y (1989). |
J. Med. Chem. 32(8) 1782-8. |
Pop, E. et al., CA 111(11): 96920j (1989). |
J. Med. Chem., 32(8), 1774-81. |